Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Antares Pharma Company Profile (NASDAQ:ATRS)

Consensus Ratings for Antares Pharma (NASDAQ:ATRS) (?)
Ratings Breakdown: 1 Sell Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $5.67 (159.94% upside)

Analysts' Ratings History for Antares Pharma (NASDAQ:ATRS)
Show:
DateFirmActionRatingPrice TargetDetailsShare
5/9/2014OppenheimerLower Price TargetOutperform$6.00 -> $5.00ViewTweet This Rating  Share This Rating on StockTwits
5/5/2014Ladenburg ThalmannLower Price Target$6.50 -> $6.00ViewTweet This Rating  Share This Rating on StockTwits
4/7/2014TheStreetDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
10/15/2013Ladenburg ThalmannBoost Price TargetBuy$5.75 -> $6.50ViewTweet This Rating  Share This Rating on StockTwits
10/8/2013Jefferies GroupBoost Price TargetBuy$5.00 -> $6.00ViewTweet This Rating  Share This Rating on StockTwits
8/8/2013Ladenburg ThalmannBoost Price TargetBuy$5.00 -> $5.75ViewTweet This Rating  Share This Rating on StockTwits
6/21/2013OppenheimerInitiated CoverageOutperform$6.00ViewTweet This Rating  Share This Rating on StockTwits
3/14/2013Jefferies GroupReiterated RatingBuy -> In-Line$5.00ViewTweet This Rating  Share This Rating on StockTwits
12/19/2012Jefferies GroupInitiated CoverageBuy$5.00ViewTweet This Rating  Share This Rating on StockTwits
11/26/2012GuggenheimInitiated CoverageBuy$6.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2012 forward)